ISSN: 0090-3973
Page Count: 4
Risk Assessment for Halogenated Solvents
Travis, CC
Office of Risk Analysis,
Oak Ridge National Laboratory,
TN
Abstract
A recent development in the cancer risk area is the advent of biologically based pharmacokinetic and pharmacodynamic models. These models allow for the incorporation of biological and mechanistic data into the risk assessment process. These advances will not only improve the risk assessment process for halogenated solvents but will stimulate and guide basic research in the biological area.
Keywords:
pharmacokinetics, pharmacodynamics, risk assessment
Paper ID: JTE11099J
DOI: 10.1520/JTE11099J
ASTM International is a member of CrossRef.
Author
Title Risk Assessment for Halogenated Solvents
Symposium , 0000-00-00
Committee E31